Riccarda Granata

Title: Riccarda Granata: Innovator in Metabolic Disorder Treatments

Introduction

Riccarda Granata is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of metabolic disorders through her innovative research and patenting efforts. Her work focuses on the therapeutic potential of unacylated ghrelin, a polypeptide that plays a crucial role in glucose metabolism.

Latest Patents

Granata holds a patent for "Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders." This patent describes an isolated polypeptide comprising any amino acid fragment of unacylated ghrelin or any analog thereof. The polypeptide exhibits activities such as decreasing blood glucose levels, increasing insulin secretion and/or sensitivity, binding to insulin-secreting cells, and promoting the survival of insulin-secreting cells. The patent also outlines the use of this polypeptide in treating disorders associated with impaired glucose metabolism. She has 1 patent to her name.

Career Highlights

Granata is affiliated with Alize Pharma Sas, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating metabolic disorders, which are increasingly prevalent in today's society.

Collaborations

Throughout her career, Granata has collaborated with notable professionals in her field, including Ezio Ghigo and Aart Jan Van Der Lely. These collaborations have enriched her research and contributed to the advancement of therapeutic strategies for metabolic disorders.

Conclusion

Riccarda Granata is a trailblazer in the field of metabolic disorder treatments, with her innovative patent on unacylated ghrelin showcasing her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches to managing glucose metabolism disorders.